Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 5/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | IKBKE | Q14164 | 1/20 | 0.30 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.30 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.30 |
| ▸ | AURKA | O14965 | 1/20 | 0.30 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6392030 | 0.86 | NPC1 (0.39) | TYMSNPC1ALDH1A1LMNAMAPT | |
| SCHEMBL6394520 | 0.84 | TYMS (0.34) | TYMSNPC1ALDH1A1LMNAMAPT | |
| SCHEMBL6390631 | 0.81 | PTPRB (0.35) | TYMSNPC1ALDH1A1LMNAMAPK1 | |
| SCHEMBL6390770 | 0.81 | FABP3 (0.36) | TYMSCYP1A2MAPTSMN1; SMN2PGAM1 | |
| SCHEMBL6390637 | 0.79 | TYMS (0.38) | TYMSALDH1A1MAPTMAPK1PGAM1 | |
| SCHEMBL6389483 | 0.77 | TIMP3 (0.39) | TYMSCYP1A2ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL6390574 | 0.77 | ELANE (0.38) | TYMSCYP1A2L3MBTL1AURKAAURKB | |
| SCHEMBL6390530 | 0.76 | ELANE (0.39) | TYMSBCHEACHEPGAM1 | |
| SCHEMBL6386963 | 0.76 | ALDH1A1 (0.40) | TYMSNPC1ALDH1A1LMNAMAPT | |
| SCHEMBL6395149 | 0.75 | ELANE (0.36) | TYMSCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050040373-A1 | Dopant and conductive polymer material therewith | MITSUI CHEMICALS, INC. (JP) | 2005-02-24 | — | — | US | disclosed |
| US-6814888-B2 | FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR | MITSUI CHEMICALS, INC. (JP) | 2004-11-09 | — | — | US | disclosed |
| US-20030142462-A1 | Dopant agent and electroconductive polymer material comprising the same | MITSUI CHEMICALS, INC. (JP) | 2003-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030142462-A1 | Dopant agent and electroconductive polymer material comprising the same | RPS6, H1-10, H1-0 | TYMS 4742/4885BCHE 4498/4885ACHE 4268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.